专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

2. 发明公开

EP1293837A3 Electrophotographic organophotoreceptors 有权
标题翻译：一种电子照相有机感光体
公开(公告)号：EP1293837A3
公开(公告)日：2004-03-03
申请号：EP02256280.5
申请日：2002-09-11
申请人： SAMSUNG ELECTRONICS CO., LTD.
发明人： Law, Kam W. , Jubran, Nusrallah , Tokarski, Zbigniew , Katritzky, Alan R. , Jain, Ritu , Maimait, Rexiat , Vakulenko, Anatoliy V.
IPC分类号： G03G5/06 , C07D333/48 , C07D207/34 , C07C251/84 , C07D257/06 , C07D249/18 , C07C317/34 , C07D231/38
CPC分类号： G03G5/0612 , G03G5/0616
摘要： An organophotoreceptor that includes (a) a charge transport material having the formula wherein A is selected from heterocyclic groups, naphthyl group, (9H-fluoren-9-ylidene)benzyl group, alkylsulfonylphenyl, or stilbenyl, B is selected from hydrogen, alkyl group, and an aryl group, with the proviso that when A is naphthyl, B is naphthyl; and wherein R 1 is selected from the group consisting of N-pyrrolyl, N-pyrazolyl, N-tetrazolyl, N-indolyl, N-carbazolyl, N-triazolyl, N-imidazolyl, N-benzimidazolyl, N-indazolyl, and N-benzotriazolyl group, and R 3 is a 9-fluorenone group, (b) a charge generating compound, and (c) an electrically conductive substrate. Therefore, an organophotoreceptor having good mechanical and electrostatic properties can be obtained by using a charge transport material including 9H-fluoren-9-one hydrazino substituted compounds and derivatives thereof. Also, an electrophotographic imaging apparatus for obtaining high quality image even after repeated cycles can be attained by employing the organophotoreceptor.

3. 发明公开

EP1335250A1 Electrophotographic organophotoreceptors with novel charge transport materials 审中-公开
标题翻译： Elektrophotographische organische Photoleiter，neue Ladungstransportmaterialien enthaltend
公开(公告)号：EP1335250A1
公开(公告)日：2003-08-13
申请号：EP03250767.5
申请日：2003-02-06
申请人： SAMSUNG ELECTRONICS CO., LTD.
发明人： Law, Kam W. , Jubran, Nusrallah , Tokarski, Zbigniew , Katritzky, Alan R. , Jain, Ritu , Maimait, Rexiat
IPC分类号： G03G5/06 , C07D333/48 , C07C251/84 , C07C317/34 , C07D249/18 , C07D231/38 , C07D257/06 , C07D207/34
CPC分类号： C07D231/38 , C07C251/84 , C07C317/34 , C07C2603/18 , C07D207/34 , C07D249/18 , C07D257/06 , C07D333/48 , G03G5/0616 , G03G5/0618 , G03G5/062 , G03G5/0661
摘要： This invention relates to a novel organophotoreceptor comprising:

(a) at least one charge transport material comprising a fluorenone hydrazone having a combination of groups thereon, the combination of groups being selected from the group consisting of a) at least two fluorenone alkylsulfonylphenylhydrazone groups, b) at least two fluorenone pyrrolylhydrazone groups, c) at least two fluorenone benzotriazolylhydrazone groups, d) at least two fluorenone sulfolanylhydrazone groups, e) at least two fluorenone pyrazolylhydrazone groups, f) at least two fluorenone naphthylhydrazone groups, g) at least two fluorenone tetrazolylhydrazone groups, h) at least two fluorenone stilbenylhydrazone groups, and i) at least two fluorenone (9H-fluoren-9-ylidene)benzylhydrazone groups. Some of these fluorenones may be represented by the formula
where n is an integer between 2 and 6, inclusive; R 1 is hydrogen, an alkyl group, or an aryl group (e.g., phenyl, naphthyl, stilbenyl, benzyl, or tolanyl group); R 2 is an alkylsulfonylphenyl or one of its derivatives; X is a linking group having the formula -(CH 2 ) m -, branched or linear. The compounds may form electrostatic imaging systems in combination with
(b) a charge generating compound; and
(c) an electrically conductive substrate.
摘要翻译：本发明涉及一种新的有机光感受器，其包含：（a）至少一种电荷传输材料，其包含其上具有基团的组合的芴酮腙，所述组合选自a）至少两个芴酮烷基磺酰基苯基腙基团，b ）至少两个芴酮吡咯基腙基团，c）至少两个芴酮苯并三唑基腙基团，d）至少两个芴酮砜基腙基团，e）至少两个芴酮吡唑基腙基团，f）至少两个芴酮萘基腙基团，g）至少两个芴酮四唑基腙基，h）至少两个芴酮二苯乙烯基腙基，和i）至少两个芴酮（9H-芴-9-亚基）苄腙基团。这些芴酮中的一些可以由式CHEM表示，其中n是2和6之间的整数，包括0和6; R1是氢，烷基或芳基（例如苯基，萘基，茋基，苄基或甲苯酰基）; R2是烷基磺酰基苯基或其衍生物之一; X是具有式 - （CH 2）m - ，支链或直链的连接基团。所述化合物可以与（b）产生电荷的化合物组合形成静电成像系统; 和（c）导电基板。

4. 发明公开

EP0258773A2 Benzothiazolones, their production and use as herbicides 失效
标题翻译：苯并噻唑酮，我的Herstellung和Anwendung als Herbizide。
公开(公告)号：EP0258773A2
公开(公告)日：1988-03-09
申请号：EP87112245.3
申请日：1987-08-24
申请人： SUMITOMO CHEMICAL COMPANY, LIMITED
发明人： Haga, Toru , Nagano, Eiki , Sato, Ryo , Morita, Kouichi
IPC分类号： C07D417/04 , A01N43/82 , C07D271/10 , C07C251/84
CPC分类号： C07D271/07 , A01N43/82 , C07C243/00 , C07D417/04
摘要： A compound of the formula:
wherein R¹ is a C₁-C₅ alkyl group, a C₃-C₄ alkenyl group, a C₃-C₄ alkynyl group or a C₁-C₂ alkoxy(C₁-C₂)alkyl group, R² is a t-butyl group or a 1-methylcyclopropyl group and X is a fluorine atom or a chlorine atom, which is useful as a herbicide.
摘要翻译：下式化合物：其中R 1为C 1 -C 5烷基，C 3 -C 4烯基，C 3 -C 4炔基或C 1 -C 2烷氧基（C 1 -C 2）烷基，R 2是叔丁基或1-甲基环丙基，X是氟原子或氯原子，可用作除草剂。

5. 发明授权

EP2528893B1 SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS 有权
公开(公告)号：EP2528893B1
公开(公告)日：2018-10-10
申请号：EP11737834.9
申请日：2011-01-31
申请人： Dana-Farber Cancer Institute, Inc.
发明人： WALENSKY, Loren, D. , STEWART, Michelle, L. , COHEN, Nicole
IPC分类号： C07C251/20 , C07D215/16 , C07D249/08 , A61K31/41 , A61P35/00 , C07D403/04 , C07D403/08 , C07C335/16 , C07C251/84
CPC分类号： C07D513/04 , C07C251/20 , C07C251/84 , C07C311/20 , C07C335/16 , C07C337/08 , C07C2602/10 , C07D239/60 , C07D249/12 , C07D277/34 , C07D279/06 , C07D307/54 , C07D327/04 , C07D401/12 , C07D403/04 , C07D403/06 , C07D403/08 , C07D405/12 , C07D405/14 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/06 , C07D413/14 , C07D417/04 , C07D417/14
摘要： This invention relates to compounds which selectively bind to the survival protein MCL-1 with high affinity and selectivity, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for modulating MCL-1 activity and for treating hyperproliferative disorders, angiogenesis disorders, cell cycle regulation disorders, autophagy regulation disorders, inflammatory disorders, and/or infectious disorders and/or for enhancing cellular engraftment and/or wound repair, as a sole agent or in combination with other active ingredients.

6. 发明公开

EP3033326A4 DEGRADABLE HYDRAZONE CURING AGENTS AND APPLICATIONS THEREOF 审中-公开
标题翻译： ABBAUBAREHYDRAZONHÄRTERUND ANWENDUNGEN DAVON
公开(公告)号：EP3033326A4
公开(公告)日：2017-04-19
申请号：EP14847604
申请日：2014-09-24
申请人： ADESSO ADVANCED MAT WUXI CO LTD
发明人： QIN BING , LI XIN , LIANG BO
IPC分类号： C07C251/76 , C07C249/16 , C07C251/84 , C07C251/86 , C08G59/50 , C08L63/00
CPC分类号： C08G59/4014 , C07C251/76 , C07C251/84 , C07C251/86 , C07C317/32 , C08G59/245 , C08G59/4064 , C08G59/50 , C08G59/5046 , C08J5/042 , C08J5/24 , C08J11/16 , C08J11/24 , C08J2363/02 , C09D163/00
摘要： This invention provides, among others, curing agents of Formula II, methods for preparing these curing agents, prepreg materials, degradable cross-linked polymers and reinforced composites made from these curing agents and epoxy resins, and methods for degrading and/or recycling the degradable polymers and reinforced composites.
摘要翻译：本发明尤其提供了式II的固化剂，这些固化剂的制备方法，预浸料材料，可降解交联聚合物和由这些固化剂和环氧树脂制成的增强复合材料，以及降解和/或回收可降解的聚合物和增强复合材料。

7. 发明公开

EP2888240A4 COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS 审中-公开
标题翻译：用于治疗副乳杆菌感染的化合物
公开(公告)号：EP2888240A4
公开(公告)日：2016-04-27
申请号：EP13830584
申请日：2013-08-21
申请人： ALIOS BIOPHARMA INC
发明人： WANG GUANGYI , BEIGELMAN LEONID , TRUONG ANH , NAPOLITANO CARMELA , ANDREOTTI DANIELE , HE HAIYING
IPC分类号： C07D333/52 , C07C251/84 , C07C251/86 , C07D207/00 , C07D209/04 , C07D213/00 , C07D215/00 , C07D217/00 , C07D233/60 , C07D235/02 , C07D249/04 , C07D249/18 , C07D261/02 , C07D265/00 , C07D307/02 , C07D307/78 , C07D311/02 , C07D333/02 , C07D335/04 , C07D401/00
CPC分类号： C07D495/04 , A61K31/165 , A61K31/277 , A61K31/341 , A61K31/343 , A61K31/352 , A61K31/381 , A61K31/382 , A61K31/40 , A61K31/4025 , A61K31/404 , A61K31/407 , A61K31/4155 , A61K31/4164 , A61K31/4196 , A61K31/423 , A61K31/426 , A61K31/427 , A61K31/428 , A61K31/4365 , A61K31/4375 , A61K31/4418 , A61K31/4427 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/47 , A61K31/4704 , A61K31/4709 , A61K31/4725 , A61K31/496 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/5377 , A61K31/538 , A61K45/06 , C07C243/18 , C07C243/34 , C07C251/80 , C07C251/84 , C07C255/34 , C07C255/66 , C07C2602/08 , C07D207/335 , C07D209/08 , C07D209/14 , C07D209/20 , C07D209/86 , C07D213/42 , C07D213/50 , C07D213/65 , C07D213/68 , C07D215/12 , C07D215/14 , C07D215/38 , C07D215/42 , C07D217/24 , C07D233/38 , C07D233/60 , C07D233/61 , C07D233/64 , C07D233/88 , C07D261/20 , C07D277/56 , C07D277/64 , C07D307/40 , C07D307/52 , C07D307/81 , C07D307/91 , C07D311/68 , C07D333/16 , C07D333/20 , C07D333/50 , C07D333/54 , C07D333/58 , C07D333/62 , C07D333/66 , C07D333/68 , C07D333/76 , C07D335/06 , C07D401/04 , C07D401/10 , C07D401/12 , C07D405/04 , C07D405/10 , C07D405/12 , C07D409/04 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/12 , C07D471/04 , C07D495/14 , A61K2300/00
摘要： Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).
摘要翻译：本文公开了新的抗病毒化合物以及包含一种或多种抗病毒化合物的药物组合物及其合成方法。本文还公开了用一种或多种小分子化合物改善和/或治疗副粘病毒病毒感染的方法。副粘病毒感染的实例包括由人呼吸道合胞病毒（RSV）引起的感染。

8. 发明授权

EP1498411B1 DIKETOHYDRAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT 有权
标题翻译： DIKETOHYDRAZINDERIVATVERBINDUNGEN及药物的化合物作为活性CONTAIN
公开(公告)号：EP1498411B1
公开(公告)日：2013-01-16
申请号：EP03723188.3
申请日：2003-04-24
申请人： ONO PHARMACEUTICAL CO., LTD.
发明人： HATAYAMA, Akira, c/o Ono Pharmaceutical Co. Ltd. , TSURUTA, Hiroshi, c/o Ono Pharmaceutical Co. Ltd. , OCHI, Yasuo, c/o Ono Pharmaceutical Co. Ltd. , IMAWAKA, Haruo, c/o Ono Pharmaceutical Co. Ltd. , OHMOTO, Kazuyuki c/o Ono Pharmaceutical Co. Ltd.
IPC分类号： C07C243/24 , C07C251/76 , C07C251/84 , C07C251/86 , C07D207/22 , C07D207/408 , C07D207/50 , C07D211/26 , C07D213/53 , C07D231/08 , C07D233/32 , C07D263/26 , C07D275/02 , C07D277/18 , C07D307/52 , C07D309/04 , C07D309/06 , C07D405/12 , C07D413/12 , C07D417/12 , C07D487/04
CPC分类号： C07D209/48 , A61K31/16 , A61K31/165 , A61K31/341 , A61K31/351 , A61K31/40 , A61K31/4025 , A61K31/4035 , A61K31/4152 , A61K31/4166 , A61K31/4168 , A61K31/421 , A61K31/423 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/428 , A61K31/429 , C07C243/34 , C07C251/76 , C07C251/84 , C07C251/86 , C07C2601/08 , C07C2601/14 , C07D207/22 , C07D207/50 , C07D209/46 , C07D211/28 , C07D211/72 , C07D211/86 , C07D211/98 , C07D213/70 , C07D213/76 , C07D213/77 , C07D213/78 , C07D233/38 , C07D233/52 , C07D233/80 , C07D239/10 , C07D239/18 , C07D239/36 , C07D241/08 , C07D241/18 , C07D263/26 , C07D263/28 , C07D265/08 , C07D265/10 , C07D265/33 , C07D275/02 , C07D275/03 , C07D275/06 , C07D277/18 , C07D277/36 , C07D277/50 , C07D277/54 , C07D277/60 , C07D277/82 , C07D279/02 , C07D279/06 , C07D279/12 , C07D285/10 , C07D285/16 , C07D309/04 , C07D309/28 , C07D335/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D513/10 , C07F9/591 , C07F9/65583 , Y02A50/411
摘要： The present invention relates to a diketohydrazine derivative of formula (I) and a pharmaceutically acceptable salt thereof (the symbols in the formula have the same meaning as described in the specification). The compound of formula (I) has an inhibitory activity against cysteine protease, and it is useful for the treatment of inflammatory diseases, immune diseases, ischemic diseases, respiratory diseases, circulatory diseases, blood diseases, neuronal diseases, hepatic or biliary diseases, osseous or articular diseases, metabolic diseases, etc. And the compound has inhibitory activity against elastase and it is also useful for the treatment of COPD (chronic obstacle pulmonary diseases).

9. 发明公开

EP1668026A1 DETECTION OF CHOLESTEROL OZONATION PRODUCTS 审中-公开
标题翻译： NACHWEIS VON CHOLESTERIN-OZONIERUNGSPRODUKTEN
公开(公告)号：EP1668026A1
公开(公告)日：2006-06-14
申请号：EP04783348.8
申请日：2004-09-03
申请人： THE SCRIPPS RESEARCH INSTITUTE
发明人： WENTWORTH, Paul , LERNER, Richard, A.
IPC分类号： C07J9/00 , C07J61/00 , C07J41/00 , C07C49/507 , C07C49/633 , G01N33/53 , C07C251/76 , C07C251/84 , C07C251/82 , C07C311/49 , C07D313/04 , C07D315/00
CPC分类号： C07K16/44 , C07C35/44 , C07C49/523 , C07C49/757 , C07C251/76 , C07C251/82 , C07C251/84 , C07C311/49 , C07C2601/14 , C07C2601/16 , C07C2602/08 , C07C2602/24 , C07C2603/40 , C07D313/04 , C07J9/00 , C07J41/0005 , C07J61/00 , C07K16/18 , G01N33/92 , G01N2800/044
摘要： The invention relates to detection of cholesterol ozonation products that are generated by atherosclerotic plaque material, and to methods of detecting vascular conditions that relate to the accumulation and oxidation of cholesterol.
摘要翻译：本发明涉及由动脉粥样硬化斑块材料产生的胆固醇臭氧化产物的检测，以及检测与胆固醇积聚和氧化相关的血管病症的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式